Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damageWILKE, Russell A; MOORE, Jason H; BURMESTER, James K et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 6, pp 415-421, issn 1744-6872, 7 p.Article

The unique complexity of the CYP3A4 upstream region suggests a nongenetic explanation of its expression variabilityHUAN QIU; MATHÄS, Marianne; NESTLER, Sebastian et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 3, pp 167-178, issn 1744-6872, 12 p.Article

Inhibitory effects of fruit juices on CYP3A activityKIM, Hyunmi; YOON, Yune-Jung; SHON, Ji-Hong et al.Drug metabolism and disposition. 2006, Vol 34, Num 4, pp 521-523, issn 0090-9556, 3 p.Article

Constitutive and xenobiotics-induced expression of a novel CYP3A gene from zebrafish larvaTSENG, Hua-Pin; HSEU, Tzong-Hsiung; BUHLER, Donald R et al.Toxicology and applied pharmacology. 2005, Vol 205, Num 3, pp 247-258, issn 0041-008X, 12 p.Article

Metabolism of alfentanil by cytochrome P4503A (CYP3A) enzymesMARIERO KLEES, Theresa; SHEFFELS, Pamela; DALE, Ola et al.Drug metabolism and disposition. 2005, Vol 33, Num 3, pp 303-311, issn 0090-9556, 9 p.Article

Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotypingSTREETMAN, Daniel S; KASHUBA, Angela D. M; BERTINO, Joseph S et al.Pharmacogenetics (London). 2001, Vol 11, Num 4, pp 349-355, issn 0960-314XArticle

Possible existence of a CYP3A protein in liver microsomes from female ratsSTROTKAMP, D; ROOS, P; HANSTEIN, W. G et al.Biological chemistry Hoppe-Seyler. 1993, Vol 374, Num 12, pp 1093-1098, issn 0177-3593Article

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipientsROY, Jean Nicholas; BARAMA, Azemi; POIRIER, Charles et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 9, pp 659-665, issn 1744-6872, 7 p.Article

A pilot study on risperidone metabolism : The role of cytochromes P450 2D6 and 3ABORK, J. A; ROGERS, T; WEDLUND, P. J et al.The Journal of clinical psychiatry. 1999, Vol 60, Num 7, pp 469-476, issn 0160-6689Article

Human liver cytochrome P4503A biotransformation of the cyclosporin derivative SDZ IMM 125VICKERS, A. E. M; MEYER, E; DANNECKER, R et al.Drug metabolism and disposition. 1995, Vol 23, Num 3, pp 321-326, issn 0090-9556Article

The influence of age and sex on the clearance of cytochrome P450 3A substratesCOTREAU, Monette M; VON MOLTKE, Lisa L; GREENBLATT, David J et al.Clinical pharmacokinetics. 2005, Vol 44, Num 1, pp 33-60, issn 0312-5963, 28 p.Article

Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species différences and interindividual variation in manGIBSON, G. G; PLANT, N. J; SWALES, K. E et al.Xenobiotica (London. Print). 2002, Vol 32, Num 3, pp 165-206, issn 0049-8254Article

Identification of cytochrome P4503A as the major subfamily responsible for the metabolism of roquinimex in manTUVESSON, H; WIENKERS, L. C; GUNNARSSON, P. O et al.Xenobiotica (London. Print). 2000, Vol 30, Num 9, pp 905-914, issn 0049-8254Article

Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liverJÖNSSON, G; ASTRÖM, A; ANDERSSON, P et al.Drug metabolism and disposition. 1995, Vol 23, Num 1, pp 137-142, issn 0090-9556Article

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish populationMIRGHANI, Rajaa A; SAYI, Jane; BERTILSSON, Leif et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 9, pp 637-645, issn 1744-6872, 9 p.Article

Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populationsSCHIRMER, Markus; TOLIAT, Mohammad R; HABERL, Michael et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 1, pp 59-71, issn 1744-6872, 13 p.Article

Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humansLAMBA, Jatinder K; XIN CHEN; SCHUETZ, John D et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 6, pp 415-427, issn 1744-6872, 13 p.Article

Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissuesMATHENY, Christopher J; ALI, Rabia Y; XIAODONG YANG et al.Drug metabolism and disposition. 2004, Vol 32, Num 9, pp 1008-1014, issn 0090-9556, 7 p.Article

Effect of troglitazone on urinary excretion of 6β-hydroxycortisolKOUP, J. R; ANDERSON, G. D; LOI, C.-M et al.Journal of clinical pharmacology. 1998, Vol 38, Num 9, pp 815-818, issn 0091-2700Conference Paper

Metabolism of drugs by cytochrome P450 3A isoforms : implications for drug interactions in psychopharmacology. DiscussionVON MOLTKE, L. L; GREENBLATT, D. J; SCHMIDER, J et al.Clinical pharmacokinetics. 1995, Vol 29, pp 33-44, issn 0312-5963, SUP1Conference Paper

Induction of CYP3A by Ethanol in multiple In vitro and In vivo modelsFEIERMAN, Dennis E; MELINKOV, Zoya; NANJI, Amin A et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 6, pp 981-988, issn 0145-6008, 8 p.Article

The emerging role of cytochrome P450 3A in psychopharmacologyKETTER, T. A; FLOCKHART, D. A; POST, R. M et al.Journal of clinical psychopharmacology. 1995, Vol 15, Num 6, pp 387-398, issn 0271-0749Article

Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidineWRIGHTON, S. A; RING, B. J.Pharmaceutical research. 1994, Vol 11, Num 6, pp 921-924, issn 0724-8741Article

The effect of anesthesia and surgery on CYP3A activity in ratsUHING, Michael R; BENO, David W. A; JIYAMAPA-SERNA, Vanida A et al.Drug metabolism and disposition. 2004, Vol 32, Num 11, pp 1325-1330, issn 0090-9556, 6 p.Article

Genomic organization of the human CYP3A locus : identification of a new, inducible CYP3A geneGELLNER, Klaus; EISELT, Regina; BISHOP, Cheryl et al.Pharmacogenetics (London). 2001, Vol 11, Num 2, pp 111-121, issn 0960-314XArticle